Table 2 PSMA-PET/mpMRI and Acetate-PET parameters.

From: The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography

 

FA (°)

MS (px)

Avgs.(No.)

TE (ms)

TR (ms)

PS (mm)

ST (mm)

DCE

20

256 × 256

1

1.82–1.90

4.03–4.49

1.00/1.00

5.0

DWI

90

256 × 256

4

73.0–73.5

3500–4500

0.94/0.94

5.0

T2w (Ax)

125

512 × 512

1

95.7–104.3

3730–10,941

0.41/0.41

2.5

T2w (Sag)

111

512 × 512

3

125.2–134.9

4922–7482

0.47/0.47

3.0

T2w (Cor)

111

512 × 512

3

125.2–134.9

6133

0.47/0.47

3.0

T2w ex-vivo

111

512 × 512

15

117

2500

0.20/0.20

5.0

VFA

2, 15

256 × 256

2

1.776

4.892–4.908

1.02/1.02

5.0

PSMA-PET

256 × 256

2.34/2.34

2.8

Acetate-PET

256 × 256

2.73/2.73

3.3

  1. DCE dynamic contrast enhanced imaging, DWI diffusion-weighted imaging, Ax transaxial, Sag sagittal, Cor coronal, T2w T2-weighted, VFA variable flip angle, PSMA prostate-specific membrane antigen, PET positron emission tomography. FA flip angle, MS matrix size, Avgs. no. averages, TE echo time, TR repetition time, PS in-plane pixel size, ST slice thickness.